Voloridge Investment Management
AXSM icon

Voloridge Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Voloridge Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-235,383
Closed -$27.5M – 1163
2025
Q1 		$27.5M Buy
+235,383
New +$26.8M 0.1% 269
2023
Q1 		– Sell
-53,680
Closed -$4.14M – 1361
2022
Q4 		$4.14M Sell
53,680
-160,113
-75% -$9.57M 0.02% 712
2022
Q3 		$9.54M Buy
213,793
+101,384
+90% +$5.07M 0.05% 457
2022
Q2 		$4.3M Sell
112,409
-102,810
-48% -$3.25M 0.02% 731
2022
Q1 		$8.91M Buy
215,219
+28,894
+16% +$896K 0.05% 444
2021
Q4 		$7.04M Sell
186,325
-91,315
-33% -$3.36M 0.04% 581
2021
Q3 		$9.15M Buy
+277,640
New +$10.8M 0.06% 461
2021
Q2 		– Sell
-13,020
Closed -$737K – 1603
2021
Q1 		$737K Buy
+13,020
New +$916K 0.01% 1104
2020
Q2 		– Sell
-7,285
Closed -$429K – 1250
2020
Q1 		$429K Buy
+7,285
New +$594K 0.01% 758

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Voloridge Investment Management's AXSM Position: Q2 2025 in Review

Voloridge Investment Management sold out of Axsome Therapeutics (AXSM) in Q2 2025, closing a stake of 235,383 shares — an estimated $27.5M sold.

Voloridge Investment Management first reported a position in AXSM in Q1 2020 and held it in 9 quarters. The position peaked at $27.5M in Q1 2025. 348 funds tracked by Wall St. Rank hold AXSM as of Q2 2025.

  • Voloridge Investment Management reported no remaining Axsome Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 235,383 Axsome Therapeutics shares in Q2 2025, an estimated $27.5M.
  • Voloridge Investment Management first reported a position in Axsome Therapeutics in Q1 2020 and held it in 9 quarters.
  • Voloridge Investment Management's Axsome Therapeutics position peaked at $27.5M in Q1 2025.
  • 348 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.